Logo image of KBSX

FST CORP (KBSX) Stock Fundamental Analysis

NASDAQ:KBSX - Nasdaq - KYG3R23E1004 - Common Stock - Currency: USD

1.47  -0.07 (-4.55%)

After market: 1.47 0 (0%)

Fundamental Rating

1

Overall KBSX gets a fundamental rating of 1 out of 10. We evaluated KBSX against 30 industry peers in the Leisure Products industry. Both the profitability and financial health of KBSX have multiple concerns. KBSX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KBSX had negative earnings in the past year.
In the past year KBSX has reported a negative cash flow from operations.
KBSX Yearly Net Income VS EBIT VS OCF VS FCFKBSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

The Return On Assets of KBSX (-8.60%) is worse than 63.33% of its industry peers.
KBSX has a Return On Equity (-9.63%) which is in line with its industry peers.
Industry RankSector Rank
ROA -8.6%
ROE -9.63%
ROIC N/A
ROA(3y)-4.76%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KBSX Yearly ROA, ROE, ROICKBSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

KBSX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KBSX Yearly Profit, Operating, Gross MarginsKBSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, KBSX has less shares outstanding
Compared to 1 year ago, KBSX has a worse debt to assets ratio.
KBSX Yearly Shares OutstandingKBSX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M
KBSX Yearly Total Debt VS Total AssetsKBSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 10.48 indicates that KBSX is not in any danger for bankruptcy at the moment.
KBSX's Altman-Z score of 10.48 is amongst the best of the industry. KBSX outperforms 96.67% of its industry peers.
KBSX has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
KBSX has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: KBSX outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 10.48
ROIC/WACCN/A
WACCN/A
KBSX Yearly LT Debt VS Equity VS FCFKBSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

KBSX has a Current Ratio of 0.01. This is a bad value and indicates that KBSX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.01, KBSX is not doing good in the industry: 96.67% of the companies in the same industry are doing better.
KBSX has a Quick Ratio of 0.01. This is a bad value and indicates that KBSX is not financially healthy enough and could expect problems in meeting its short term obligations.
KBSX's Quick ratio of 0.01 is on the low side compared to the rest of the industry. KBSX is outperformed by 96.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
KBSX Yearly Current Assets VS Current LiabilitesKBSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for KBSX have decreased strongly by -211.81% in the last year.
EPS 1Y (TTM)-211.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.77%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KBSX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KBSX Price Earnings VS Forward Price EarningsKBSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KBSX Per share dataKBSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KBSX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FST CORP

NASDAQ:KBSX (6/6/2025, 8:03:21 PM)

After market: 1.47 0 (0%)

1.47

-0.07 (-4.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.82%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap89.93M
AnalystsN/A
Price TargetN/A
Short Float %0.2%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.2
P/tB 2.2
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.67
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.6%
ROE -9.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.76%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 10.48
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-211.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-89.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.57%
OCF growth 3YN/A
OCF growth 5YN/A